Followers | 504 |
Posts | 10140 |
Boards Moderated | 0 |
Alias Born | 04/28/2014 |
Friday, July 10, 2015 1:21:23 PM
bullish
inverted head and shoudlers bottom reversal
## source: finance.yahoo.com
Mon, 29 Jun 2015 14:27:00 GMT ~ Nutritional Supplement Industry Flexes its Muscles as Natural & Pharmaceutical Supplement Products Continue to Hit the Market - Company Prepares for Strong Revenue Growth in 2nd Half of 2015
[PR Newswire] - One of the fastest growing industries in the world is the nutritional supplement group, or more broadly known as Vitamins, Minerals and Supplements. Axxess Pharma Inc. (AXXE) a company that develops a variety of nutritional supplements and specialty pharmaceutical products through its subsidiary company AllStar Health Brands Inc., is pleased to announce management projects a strong finish to the second half of 2015. Currently, 2015 has been a year of aggressive marketing and global approvals to sell their all-natural Tapout supplements.
read full: http://finance.yahoo.com/news/nutritional-supplement-industry-flexes-muscles-142700003.html
*********************************************************
Mon, 29 Jun 2015 13:15:08 GMT ~ RA Capital Is Expecting A Breakthrough Cancer Drug From This Biotech
read full: http://www.insidermonkey.com/blog/ra-capital-is-expecting-a-breakthrough-cancer-drug-from-this-biotech-357181/
*********************************************************
Tue, 23 Jun 2015 20:37:03 GMT ~ ARCA BIOPHARMA, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
read full: http://biz.yahoo.com/e/150623/abio8-k.html
*********************************************************
Wed, 17 Jun 2015 16:21:02 GMT ~ ARCA biopharma Announces $37 Million Private Placement
[at noodls] - Posted on June 11, 2015 ARCA BIOPHARMA ANNOUNCES $37 MILLION PRIVATE PLACEMENT --------------------------------- Proceeds to Support Advancement of Bucindolol Phase 2B/3 Clinical Development --------------------------------- ...
read full: http://www.noodls.com/view/38ABC1C005EFE6D6CF6856ABCEBFD26AD7AC1155
*********************************************************
Wed, 17 Jun 2015 16:21:02 GMT ~ ARCA biopharma Announces Closing of $37 Million Private Placement
[at noodls] - Posted on June 17, 2015 ARCA BIOPHARMA ANNOUNCES CLOSING OF $37 MILLION PRIVATE PLACEMENT --------------------------------- Proceeds to Support Advancement of Bucindolol Phase 2B/3 Clinical Development ...
read full: http://www.noodls.com/view/3D1D53A9C90F74B2703C9B3CF96E68BAA8CFC8CC
*********************************************************
$ABIO charts
basic chart ## source: stockcharts.com
basic chart ## source: stockscores.com
big daily chart ## source: stockcharts.com
big weekly chart ## source: stockcharts.com
$ABIO company information
## source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/ABIO/company-info
Ticker: $ABIO
OTC Market Place: Not Available
CIK code: 0000907654
Company name: ARCA biopharma, Inc.
Incorporated In: DE, USA
$ABIO share structure
## source: otcmarkets.com
Market Value: $23,530,236 a/o Jul 09, 2015
Shares Outstanding: 21,198,411 a/o Mar 17, 2015
Float: Not Available
Authorized Shares: Not Available
Par Value: No Par Value
$ABIO extra dd links
Company name: ARCA biopharma, Inc.
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/ABIO/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/ABIO/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=ABIO+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=ABIO+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=ABIO+Industry
## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/ABIO/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/ABIO/news - http://finance.yahoo.com/q/h?s=ABIO+Headlines
## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/ABIO/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/ABIO/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/ABIO/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/ABIO/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/ABIO/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/ABIO/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/ABIO/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/ABIO/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=ABIO+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/ABIO
DTCC (dtcc.com): http://search2.dtcc.com/?q=ARCA+biopharma%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=ARCA+biopharma%2C+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=ARCA+biopharma%2C+Inc.&x=0&y=0
## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/ABIO/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/ABIO
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/ABIO/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/ABIO/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/ABIO/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000907654&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/ABIO/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/ABIO/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/ABIO/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/ABIO/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=ABIO&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=ABIO
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/ABIO/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=ABIO+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=ABIO+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=ABIO
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=ABIO
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=ABIO+Cash+Flow&annual
## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/ABIO/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=ABIO+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/ABIO.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=ABIO
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/ABIO/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/ABIO/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/ABIO/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/ABIO/insider-transactions
## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/ABIO
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/ABIO
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/ABIO:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=ABIO
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=ABIO
$ABIO DD Notes ~ http://www.ddnotesmaker.com/ABIO
Recent ABIO News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/30/2024 09:57:33 PM
- ARCA biopharma Announces Completion of Merger with Oruka Therapeutics and Implementation of Reverse Stock Split • GlobeNewswire Inc. • 08/29/2024 08:50:15 PM
- ARCA biopharma Provides Update Regarding Special Dividend Amount in Connection with the Proposed Merger with Oruka Therapeutics • GlobeNewswire Inc. • 08/26/2024 11:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/23/2024 08:35:36 PM
- ARCA biopharma Announces 1-for-12 Reverse Stock Split in Connection with the Proposed Merger with Oruka Therapeutics • GlobeNewswire Inc. • 08/23/2024 08:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/20/2024 06:23:17 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 08/16/2024 08:27:55 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/16/2024 08:25:22 PM
- ARCA biopharma Declares Special Dividend in Connection with the Proposed Merger with Oruka Therapeutics • GlobeNewswire Inc. • 08/16/2024 08:15:00 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 08/15/2024 08:17:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/15/2024 08:15:35 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 08/09/2024 12:35:20 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 08/01/2024 08:30:02 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2024 08:25:09 PM
- ARCA biopharma Announces Second Quarter 2024 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 08/01/2024 08:15:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 08/01/2024 08:10:17 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/01/2024 08:05:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/26/2024 02:50:20 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 07/25/2024 04:15:10 AM
- Form S-4/A - Registration of securities, business combinations: [Amend] • Edgar (US Regulatory) • 07/22/2024 09:17:17 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/12/2024 11:38:10 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 07/12/2024 11:10:32 PM
- Form S-4/A - Registration of securities, business combinations: [Amend] • Edgar (US Regulatory) • 07/09/2024 09:29:01 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 07/09/2024 09:04:50 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM